No­vo Nordisk Foun­da­tion is­sues $200M grant to ap­ply quan­tum com­put­ing to life sci­ences, drug dis­cov­ery

The No­vo Nordisk Foun­da­tion, the large Dan­ish char­i­ty that owns the phar­ma­ceu­ti­cal com­pa­ny of the same name, is mak­ing a quan­tum leap.

Mak­ing a deep in­vest­ment in­to what it be­lieves is the fu­ture of life sci­ences, the foun­da­tion is pony­ing up $200 mil­lion to try to de­vel­op the world’s first quan­tum com­put­er de­signed to de­vel­op new drugs. No­vo is­sued the mon­ey in the form of a grant to launch the “No­vo Nordisk Foun­da­tion Quan­tum Com­put­ing Pro­gramme” in tan­dem with the Uni­ver­si­ty of Copen­hagen.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER